REGN Jun 2025 1280.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 01:16PM EDT. Market open.
Loading interactive chart...
- GuruFocus.com
Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)
The transaction was documented in an SEC Filing. Following this transaction, the insider now owns 17,882 shares of Regeneron Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
- Simply Wall St.
Insiders At Regeneron Pharmaceuticals Sold US$26m In Stock, Alluding To Potential Weakness
The fact that multiple Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) insiders offloaded a considerable amount of...
- Zacks
Regeneron (REGN) Gets Positive CHMP Opinion for Lymphoma Drug
Regeneron (REGN) gets positive CHMP recommendation for odronextamab for the treatment of adults with relapsed/refractory follicular lymphoma or diffuse large B-cell lymphoma.
© 2024 Yahoo. All rights reserved.